Use of Low-Molecular-Weight Heparin in the Treatment of Venous Thromboembolic Disease: Answers to Frequently Asked Questions
- 1 June 1998
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 73 (6) , 545-551
- https://doi.org/10.4065/73.6.545
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary EmbolismNew England Journal of Medicine, 1997
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismNew England Journal of Medicine, 1997
- Management of Venous ThromboembolismNew England Journal of Medicine, 1996
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at HomeNew England Journal of Medicine, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Monitoring the Anticoagulant Effects of a Low Molecular Weight Heparin Preparation:Correlation of Assays in Orthopedic Surgery Patients Receiving Ardeparin Sodium for Prophylaxis of Deep Venous ThrombosisAmerican Journal of Clinical Pathology, 1995
- Current Concepts in Anticoagulant TherapyMayo Clinic Proceedings, 1995
- Treatment of Deep Venous Thrombosis With Low-Molecular-Weight HeparinsArchives of internal medicine (1960), 1995